The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Cited by
Sorted by citations
Items 501–600 of 814
Koo, Y.-A., Shin, S.-Y., Yoon, B.-K., & Choi, D. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701492689 · Cited by 13
Minireview: Up-date management of non responder to clomiphene citrate in polycystic ovary syndrome.
Amin, M., Abdel-Kareem, O., Takekida, S., Moriyama, T., el-Aal, G. A., & Maruo, T. (2003) · PubMed · doi:10.24546/00386993 · Cited by 13
Insulinoma presenting with hyperandrogenism: a case report and a literature review
Stanciu, I., Pitale, S., Prinz, R. A., Jakate, S. M., Webb, G. C., Steiner, D. F., Braithwaite, S. S., Gordon, D., & Emanuele, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01132.x · Cited by 13
Current controversies in testosterone testing: aging and obesity
Elin, R. J., & Winters, S. J. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.01.010 · Cited by 13
Energy Balance and Cancer Prognosis, Breast Cancer
Goodwin, P. J. (2005) · Nutrition and disease prevention · doi:10.1201/9781420026641.sec7 · Cited by 13
Funktionelle Androgenisierung des peri- und postpuberalen Mädchens sowie der Frau
Geisthövel, F., & Wetzka, B. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 13
Li, J., Wang, Y., Tang, R., Peng, Y., Wang, Y., Liu, B., Jiang, Y., Liu, G., Lin, S., & Chen, R. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001531 · Cited by 12
Gupta, A., Jakubowicz, D. J., & Nestler, J. E. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0009 · Cited by 12
Self-citationGonzález, F., Mather, K. J., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00228.2020 · Cited by 12
Metformin and polycystic ovary syndrome
Lebinger, T. G. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328089f0ea · Cited by 13
Committee Opinion No. 714: Obesity in Adolescents
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002297 · Cited by 12
Insulin Action in Polycystic Ovary Syndrome: In Vivo and In Vitro
Baillargeon, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_4 · Cited by 12
Liu, Q., Gu, W., Cui, B., Hong, J., Zhang, Y., Chi, Z.-N., Su, Y., & Ning, G. (2008) · Endocrine · doi:10.1007/s12020-008-9104-8 · Cited by 12
Gut microbiota in diabetic-linked polycystic ovarian syndrome: Mechanisms and therapeutic insights
Mehta, P., Saha, D., Das, A., & Das, B. K. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102870 · Cited by 11
Zumbro, E. L., Rao, M., Balcom-Luker, S., Broughton, K. S., & LeMieux, M. J. (2021) · Nutrients · doi:10.3390/nu13072451 · Cited by 11
Khiyami, A. M., Jokar, T. O., Abdallah, H. M., Gardner, P. A., Zenonos, G. A., Styer, A. K., & Fazeli, P. K. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01057-x · Cited by 11
Association between the (TAAAA)nSHBGpolymorphism and PCOS: a systematic review and meta-analysis
Fan, W., Li, S., Chen, Q., & Huang, Z. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.797394 · Cited by 11
Hara, S., Takahashi, T., Amita, M., Igarashi, H., Tsutsumi, S., & Kurachi, H. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.090738 · Cited by 12
Akpınar, F., Dilbaz, B., Cırık, D. A., Yılmaz, S., Altınbaş, Ş. K., Karahanoğlu, E., & Mollamahmutoğlu, L. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.11.15006 · Cited by 11
Treatment of androgen excess in females: Yesterday, today and tomorrow
Pucci, E., & Petraglia, F. (1997) · Gynecological Endocrinology · doi:10.3109/09513599709152569 · Cited by 11
The endometrium in polycystic ovary syndrome
Lathi, R. B., Swiersz, L. M., Basina, M., & Giudice, L. C. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00007 · Cited by 11
Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency
Witchel, S. F., & Arslanian, S. A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00770.x · Cited by 11
Insulin Resistance Effects on Sex Hormones and Ovulation in the Polycystic Ovary Syndrome
Nestler, J. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_19 · Cited by 11
Self-citationPediatric and Adolescent Medicine
(2014) · Pediatric and adolescent medicine · doi:10.1159/issn.1017-5989 · Cited by 11
Torchen, L. C., Wu, M., Thompson, B., & Beaudouin, A. (2025) · Reproduction · doi:10.1530/rep-25-0091 · Cited by 10
Javidan, A., Azarboo, A., Jalali, S., Fallahtafti, P., Moayyed, S., Ghaemi, M., Tarafdari, A., & Hantoushzadeh, S. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01717-z · Cited by 15
Harrison, T. N. H., & Chang, R. J. (2022) · Clinical Endocrinology · doi:10.1111/cen.14708 · Cited by 10
Polycystic Ovary Syndrome in Adolescents
Saleh, F., Starkman, H., Furness, A., Pfeifer, S. M., & Kives, S. L. (2024) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2024.08.005 · Cited by 12
Chae, H. W., Kwon, A., Kim, D.-H., & Kim, H.-S. (2013) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2013.18.2.81 · Cited by 10
Higuchi, M., Mekuchi, M., Hano, T., & Imaizumi, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209063 · Cited by 11
The Relationship Between PCOS and Obesity: Which Comes First?
Rosenberg, S. L. (2019) · Touro Scholar (Touro College) · Cited by 10
Blum, M. R., Popat, R. A., Nagy, A., Cataldo, N. A., & McLaughlin, T. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01430-2 · Cited by 14
Tuorila, K., Ollila, M., Järvelin, M., Tapanainen, J. S., Franks, S., Puukka, K. S., Piltonen, T., & Morin-Papunen, L. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab456 · Cited by 11
Mojiminiyi, O. A., Safar, F. H., Al‐Rumaih, H., & Diejomaoh, M. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.526242 · Cited by 10
Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome
Detti, L., Jeffries-Boyd, H. E., Williams, L. J., Diamond, M. P., & Uhlmann, R. A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0602-3 · Cited by 10
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 10
Lu, F.-F., Wang, Z., Yang, Q., Yan, F.-S., Xu, C., Wang, M.-T., Xu, Z.-J., Cai, S.-Y., & Guan, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1438079 · Cited by 10
Vosnakis, C., Georgopoulos, N. A., Armeni, A. K., Papadakis, E. P., Roupas, N. D., Katsikis, I., & Panidis, D. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.04.014 · Cited by 9
Plasma β-endorphin levels in obese and non-obese patients with polycystic ovary disease
Guisasola, J. M. M., Guerrero, M., Alonso, F., Dı́az, F., Cordero, J., & Ferrer, J. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.1.14.22 · Cited by 9
Nagaria, T., Mohapatra, A., & Jaiswal, J. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20190309 · Cited by 9
Diabetes Mellitus as Cancer Risk: A 14-year, Cross-Sectional Analysis
Saewai, C., Fumaneeshoat, O., Thongsuksai, P., & Ingviya, T. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2205054 · Cited by 9
Jung, M.-L., Renke, T., Nowak, O., Jauckus, J., Zorn, M., Capp, E., Strowitzki, T., & Germeyer, A. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3650-0 · Cited by 9
Bayramoğlu, E., Çetinkaya, S. Ç., Özalkak, Ş., Kurnaz, E., Demirci, G., Öztürk, S., Erdeve, Ş. S., & Aycan, Z. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0524 · Cited by 9
Metabolic and cardiovascular changes in women with polycystic ovary syndrome
Meden‐Vrtovec, H., Vrtovec, B., & Osredkar, J. (2007) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2007.06.005 · Cited by 9
Intense pulsed light photoepilation in hirsute women: the role of obesity
Grippaudo, F. R., Angelini, M., Chiossi, M., & Toscano, V. (2008) · Lasers in Medical Science · doi:10.1007/s10103-008-0583-x · Cited by 9
Polycystic Ovary Syndrome and Ovulation Induction
Yildiz, B. O., & Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_35 · Cited by 9
van Bree, B. E., van der Heijden, D. M. B., van Golde, R. J. T., Brouwers, M. C. G. J., Spaanderman, M. E. A., & Valkenburg, O. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2500462 · Cited by 8
Cardiovascular health and menopause in aging women with polycystic ovary syndrome
Helvacı, N., & Yıldız, B. O. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1719067 · Cited by 8
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_33-1 · Cited by 8
Neighborhood walkability and sex steroid hormone levels in women
Aldana, S. I., Rundle, A., Clendenen, T. V., Quinn, J. W., Arslan, A. A., Afanasyeva, Y., Koenig, K. L., Liu, M., Neckerman, K. M., Thorpe, L. E., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114285 · Cited by 8
Ahmad, J., Shukla, N., Khan, A. R., Ahmed, F., & Siddiqui, M. A. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.12.003 · Cited by 8
Akın, F., Baştemir, M., & Kaptanoğlu, B. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000114210 · Cited by 8
Aubuchon, M., Lieman, H., Stein, D. T., Cohen, H. W., Isaac, B., Adel, G., Weitzman, V. N., Tetrokalashvili, M., Polotsky, A. J., & Santoro, N. F. (2009) · Reproductive Sciences · doi:10.1177/1933719109340925 · Cited by 8
Physical Activity and Cancer Incidence
Patel, A. V., & Bernstein, L. (2005) · Nutrition and disease prevention · doi:10.1201/9781420026641.sec2 · Cited by 8
Circulating neuregulin-1 levels in polycystic ovary syndrome
Arpacı, H. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1519530 · Cited by 9
Shibahara, H., Kikuchi, K., Hirano, Y., Suzuki, T., Takamizawa, S., & Suzuki, M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.021 · Cited by 8
Geisthövel, F., Wacker, A., Brabant, G. E., Botsch, F., Maechtel, A., Wetzka, B., & Ochsner, A. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 8
Theranostic implications of Nectin-4 oncoprotein in gynecologic cancers: A review
Hooks, O., Nagpal, Y., Childers, J. T., Childers, L. T., & Ahmad, S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155913 · Cited by 7
Kushnir, M. M., Nelson, H. A., & Doyle, K. J. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac010 · Cited by 7
Permadi, W., Hestiantoro, A., Ritonga, M. A., Ferrina, A., Iswari, W. A., Sumapraja, K., Muharram, R., Djuwantono, T., Wiweko, B., & Tjandrawinata, R. R. (2021) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_141_20 · Cited by 7
Polycystic ovarian disease: an overview
Kovacs, G. T. (2004) · Reviews in Gynaecological Practice · doi:10.1016/j.rigp.2004.01.003 · Cited by 7
Tsaltas, T. T., & Stokes, M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.029 · Cited by 7
Andıran, N., Yordam, N., & Kirazlı, Ş. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.12.1373 · Cited by 7
Sofer, Y., Nevo, N., Vechoropoulos, M., Shefer, G., Osher, E., Landis, N., Tordjman, K., Hammond, G. L., & Stern, N. (2018) · Endocrine Connections · doi:10.1530/ec-17-0240 · Cited by 6
Soy Isoflavones and PCOS: Role in Hormonal and Metabolic Mechanisms
Dereń, K., Michońska, I., Dymek, A., Zielińska, M., & Łuszczki, E. (2025) · Applied Sciences · doi:10.3390/app15116198 · Cited by 6
Tosi, F., Lando, M. G., Rosmini, F., Lucarini, F., Fiorio, V., Zanolin, M. E., Fiers, T., Kaufman, J., & Moghetti, P. (2025) · Human Reproduction · doi:10.1093/humrep/deaf114 · Cited by 7
Li, S., Wu, J., Lu, R., Zhou, B., Dai, H., Zhang, Z., Yang, X., & Liang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106839 · Cited by 6
Amer, S. A. K. S., Li, T. C., Samuelson, C., & Ledger, W. J. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2010.01061.x · Cited by 6
[Obesity, a main risk factor for endometrial cancer].
Ortíz-Mendoza, C. M., & Velasco-Navarro, C. (2013) · PubMed · Cited by 6
Georgopoulos, N. A., Kandaraki, E., & Panidis, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_8 · Cited by 6
Hara, S., Takahashi, T., Amita, M., Igarashi, H., & Kurachi, H. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000316265 · Cited by 6
Brink, H. V., Pea, J., & Lujan, M. E. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.10.008 · Cited by 6
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00026-1 · Cited by 6
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Bellanger, S., Battista, M., & Baillargeon, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_7 · Cited by 5
Ty, M., Shah, & Rk, G. (2013) · Cited by 6
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · doi:10.1007/s00108-006-1776-7 · Cited by 7
Resistência à insulina na pubarca precoce - Relação com os androgênios
Teixeira, R. J., Gazolla, H. M., da Cunha, S. B., Bordallo, M. A. N., & Guimarães, M. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000300011 · Cited by 6
Up-date Management of Non Responder to Clomiphene Citrate in Polycystic Ovary Syndrome
Amin, M., Abdel-Kareem, O., Takekida, S., Moriyama, T., el-Aal, G. A., & Maruo, T. (2003) · Cited by 6
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Barnes, R. B., Ehrmann, D. A., & Rosenfield, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00132-5 · Cited by 6
Abdulkarim, A., Ghafour, K. A., & Murshid, R. M. (2023) · Journal of Biomedicine and Biochemistry · doi:10.57238/jbb.2023.6315.1024 · Cited by 5
Role of Branched-Chain Amino Acids in Metabolic Changes of Polycystic Ovary Syndrome
Jia, F.-C., & Li, X. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001272 · Cited by 5
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment
Zaidieva, Z. S., & Тимуровна, У. А. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-13-102-111 · Cited by 5
Paczkowska, K., Sobczuk, J., Zawadzka, K., Jędrzejuk, D., Zembska, A., Konieczny, J., Kaszubkiewicz-Wardęga, D., Bolanowski, M., & Daroszewski, J. (2024) · Endokrynologia Polska · doi:10.5603/ep.99111 · Cited by 6
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Lee, Y. M., Han, K., Jung, J. J., Lee, K., Cho, K.-H., & Kim, Y. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4009-x · Cited by 5
Usta, C. S., Turan, G., Hocaoğlu, M., Bülbül, Ç. B., Kılıc, K., Usta, A., & Adalı, E. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00423-z · Cited by 5
Polycystic Ovary Syndrome and its Relationship with Infertility and its Management
Jahan, Z., & Wing, K. E. (2020) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v39i1.50458 · Cited by 5
Massin, N., Galey, J., Basille, C., Théron-Gérard, L., Bry‐Gauillard, H., Cédrin‐Durnerin, I., & Hugues, J. (2003) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(03)00046-8 · Cited by 5
Walch, K., Grimm, C., Nagele, F., Huber, J. C., Wölfler, M. M., Vytiska‐Binstorfer, E., Unfried, G., & Hefler, L. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340500342938 · Cited by 5
Polycystic ovarian syndrome: a new perspective.
Ahmed, Y., Akhtar, A. S. M., Qureshi, F., Qureshi, F., Anjum, Q., & Anhalt, H. (2003) · PubMed · Cited by 5
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
Sex Hormone-Binding Globulin and Metabolic Syndrome in Children and Adolescents: A Focus on Puberty
Aydın, B. K., & Winters, S. J. (2025) · Metabolites · doi:10.3390/metabo15080494 · Cited by 4
Swauger, S. E., & Crimmins, N. A. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.04.184 · Cited by 4
Altemimi, M. T., musa, A. K., & Mansour, A. A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1431 · Cited by 4
The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
Dumesic, D. A., Crespi, B. J., Padmanabhan, V., & Abbott, D. H. (2025) · Endocrinology · doi:10.1210/endocr/bqaf160 · Cited by 4
Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study
Cucinelli, F., Soranna, L., Perri, C., Barini, A., Cento, R. M., Mancuso, S., & Lanzone, A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.05.036 · Cited by 4
Avolio, E., Ferraro, S., Mocciaro, R., Pergola, G. D., Buzzanca, F., Venturella, R., Pecorella, C., Palma, G., Romano, L., Mahata, S. K., et al. (2020) · Clinical Obstetrics Gynecology and Reproductive Medicine · doi:10.15761/cogrm.1000307 · Cited by 4
Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
Paalanne, M., Vääräsmäki, M., Mustaniemi, S., Tikanmäki, M., Wehkalampi, K., Matinolli, H., Eriksson, J. G., Järvelin, M., Morin-Papunen, L. C., & Kajantie, E. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1462 · Cited by 4
Metabolic Syndrome in Polycystic Ovary Syndrome
Hsieh, Y.-C., Yang, P.-K., & Chen, M. (2021) · Fertility & Reproduction · doi:10.1142/s2661318221500158 · Cited by 4
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review